Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable cation-transporting ATPase 13A4 (ATP13A4) is a member of the P5 subfamily of P-type ATPases, predicted to function as a **cation-transporting enzyme** using energy from ATP hydrolysis to transport monoatomic cations and polyamines across cellular membranes[4][5]. While its exact physiological function remains incompletely defined, it is believed to play roles in cellular ionic homeostasis and potentially in polyamine transport. ATP13A4 is widely expressed, with RNA present in multiple tissues including the brain[2], and localizes to intracellular membranes[1]. There is currently limited evidence linking ATP13A4 to specific diseases, drug interactions, or use as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable cation-transporting ATPase 13A4 (ATP13A4).